Tag: 2026
FDA Grants Accelerated Approval to Sanofi’s Tzield® for Pediatric Stage 3 Type 1 Diabetes
The U.S. Food and Drug Administration has granted accelerated approval to Sanofi's Tzield® (teplizumab-mzwv) for children aged 8 to 17 years recently diagnosed with stage...
The FDA has outlined its updated strategy for generic drug oversight
The U.S. Food and Drug Administration (FDA) announced its modernized framework for generic drug oversight, highlighting a dual focus on enforcing rigorous quality standards...
India Dispatches 20,000 Vaccine Doses to Support Maldives’ Measles Outbreak Response
In a decisive demonstration of regional solidarity, the Government of India has dispatched 20,000 measles vaccine doses to the Republic of Maldives as the...
Kerala on High Alert as Shigella Outbreak Spreads; ‘Operation Clean Kerala’ Intensified
Kerala has declared a health alert following a surge in Shigella infections, with 93 confirmed cases and two fatalities recorded statewide as of June 8, 2026. The outbreak,...
Emergency Price Adjustment Approved for Critical Cancer Drugs Amid Raw Material Crisis
In a decisive move to counter critical domestic medicine shortages caused by global macroeconomic headwinds, the Department of Pharmaceuticals (DoP) has granted an in-principle...
Investors Show Strong Interest in Hexagon Nutrition IPO, Bids Reach 54 Times
Hexagon Nutrition Limited, a leading research-driven nutrition company, concluded its Initial Public Offering (IPO) with resounding success, achieving an overall subscription of 53.68 times...
